Ablation of CXCR4 in breast cancer cells was further shown to inhibit bone metastasis in a mouse model by attenuating the PI3K/AKT/matrix metallopeptidase 9 (MMP9) axis. The gene discussed is AKT1; the disease is breast carcinoma.